Cargando…

Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy

Detalles Bibliográficos
Autores principales: Makino, S, Kita, H, Miyatake, Y, Yokoyama, T, Kubota, K, Obata, N, Egi, M, Misumi, T, Izuta, S, Mizobuchi, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470927/
http://dx.doi.org/10.1186/cc14384
_version_ 1782376821549957120
author Makino, S
Kita, H
Miyatake, Y
Yokoyama, T
Kubota, K
Obata, N
Egi, M
Misumi, T
Izuta, S
Mizobuchi, S
author_facet Makino, S
Kita, H
Miyatake, Y
Yokoyama, T
Kubota, K
Obata, N
Egi, M
Misumi, T
Izuta, S
Mizobuchi, S
author_sort Makino, S
collection PubMed
description
format Online
Article
Text
id pubmed-4470927
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-44709272015-06-29 Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy Makino, S Kita, H Miyatake, Y Yokoyama, T Kubota, K Obata, N Egi, M Misumi, T Izuta, S Mizobuchi, S Crit Care Poster Presentation BioMed Central 2015 2015-03-16 /pmc/articles/PMC4470927/ http://dx.doi.org/10.1186/cc14384 Text en Copyright © 2015 Makino et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Makino, S
Kita, H
Miyatake, Y
Yokoyama, T
Kubota, K
Obata, N
Egi, M
Misumi, T
Izuta, S
Mizobuchi, S
Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
title Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
title_full Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
title_fullStr Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
title_full_unstemmed Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
title_short Comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
title_sort comparison between nafamostat mesilate and unfractionated heparin as anticoagulant during continuous renal replacement therapy
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470927/
http://dx.doi.org/10.1186/cc14384
work_keys_str_mv AT makinos comparisonbetweennafamostatmesilateandunfractionatedheparinasanticoagulantduringcontinuousrenalreplacementtherapy
AT kitah comparisonbetweennafamostatmesilateandunfractionatedheparinasanticoagulantduringcontinuousrenalreplacementtherapy
AT miyatakey comparisonbetweennafamostatmesilateandunfractionatedheparinasanticoagulantduringcontinuousrenalreplacementtherapy
AT yokoyamat comparisonbetweennafamostatmesilateandunfractionatedheparinasanticoagulantduringcontinuousrenalreplacementtherapy
AT kubotak comparisonbetweennafamostatmesilateandunfractionatedheparinasanticoagulantduringcontinuousrenalreplacementtherapy
AT obatan comparisonbetweennafamostatmesilateandunfractionatedheparinasanticoagulantduringcontinuousrenalreplacementtherapy
AT egim comparisonbetweennafamostatmesilateandunfractionatedheparinasanticoagulantduringcontinuousrenalreplacementtherapy
AT misumit comparisonbetweennafamostatmesilateandunfractionatedheparinasanticoagulantduringcontinuousrenalreplacementtherapy
AT izutas comparisonbetweennafamostatmesilateandunfractionatedheparinasanticoagulantduringcontinuousrenalreplacementtherapy
AT mizobuchis comparisonbetweennafamostatmesilateandunfractionatedheparinasanticoagulantduringcontinuousrenalreplacementtherapy